Keywords
neoplasms of the breast
breast
quality of life
conservative treatments
How to Cite
Abstract
Breast cancer is the most frequent malignant pathology in the female population. Its treatment has progressively evolved in the direction of breast conservation through the development of oncoplastic breast surgery, which consists of conservative management with partial mastectomy and immediate reconstruction. Patients who present breast cancer concomitantly with macromastia, represent a greater challenge in treatment due to the difficulty of generating symmetry with the contralateral breast; they also present specific symptoms related to macromastia that diminishes their quality of life. The objective of this article, is to report the case of a patient with breast cancer and macromastia, who is successfully and simultaneously managed with oncoplastic surgery of the right breast and bilateral reduction mammoplasty, obtaining adequate oncological control and significant improvement in her quality of life measured by BREAST-Q questionnaire. MÉD.UIS.2021;34(3): 93-101.
References
Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019; 321(3): 288-300.
Globocan. Breast Cancer. International Agency for Research on Cancer, World Health Organization; 2018.
Instituto Nacional de Salud. Boletín Epidemiológico Semanal: Cáncer de mama y cuello uterino, semana epidemiológica 23. Colombia. Gobierno de Colombia; 2018.
Emiroglu M, Salimoglu S, Karaali C, Sert I, Gungor O, Sert F, et al. Oncoplastic reduction mammoplasty for breast cancer in women with macromastia: Oncological long-term outcomes. Asian J Surg [Internet]. 2017; 40(1): 41-7. Disponible en: https://doi.org/10.1016/j.asjsur.2015.07.007.
Grieco MP, Bertozzi N, Grignaffini E, Raposio E. A three-year experience with medial-pedicle-based breast reduction for different mammary hypertrophy. Acta bio-med [Internet]. 2018; Atenei Parmensis, 89(3), 389. Disponible en: https://dx.doi.org/10.23750%2Fabm.v89i3.5776.
Bonilla, OA. Hiperplasia virginal mamaria asociado a hiperplasia pseudoangiomatosa del estroma mamario difuso. Rev CES Med. 2016; 30(1): 122-8.
Chadbourne EB, Zhang S, Gordon MJ, Ro EY, Ross SD, Schnur PL., et al. Clinical outcomes in reduction mammaplasty: a systematic review and meta-analysis of published studies. Mayo Clin Proc [Internet]. 2001; 76(5): 503-10. Disponible en: https://doi.org/10.4065/76.5.503.
Sotomayor L, Pérez D, Gutiérrez A. Evaluacion del impacto fisico, psicologico y social del cancer de mamas en Hospital General Universitario Cienfuegos. XXXI Fórum Científico Estudiantil Nacional de las Ciencias Médicas. 5 de febrero 2020. http://www.forumestudiantilcienciasmedicas.sld.cu/index.php/forum/2020/paper/viewFile/5/6.
American Society of Plastic Surgeons. Plastic surgery procedural statistics. American Society of Plastic Surgeons. 2018.
Cserni, G. Histological type and typing of breast carcinomas and the WHO classification changes over time. Pathologica [Internet]. 2020; 112(1): 25-41. Disponible en: https://www.pathologica.it/article/view/96.
Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology [Internet]. 2020; 77: 181-5. Disponible en: https://doi.org/10.1111/his.14091.
Weigelt B, Geyer FC, Reis-Filho JS. Histological types of breast cancer: how special are they? Mol Oncol [Internet]. 2010; 4(3): 192- 208. Disponible en: https://doi.org/10.1016/j.molonc.2010.04.004.
Taherian-Fard A, Srihari S, Ragan MA. Breast cancer classification: linking molecular mechanisms to disease prognosis. Brief Bioinform [Internet]. 2015; 16(3): 461-74. Disponible en: https://doi.org/10.1093/bib/bbu020.
Macdonald S, Oncology R, General M. Breast Cancer. Elsevier [internet]. 2016; 70 (1) Vol 70. Disponible en: 10.1016/B978-0-323-71184-5.00276-7.
Waks A, Winer E. Breast Cancer Treatment: A Review. J Am Med Assoc [internet]. 2019; 321(3):288-300. Disponible en: https://doi.org/10.1001/jama.2018.19323.
Bonilla-Sepúlveda O, Matute-Turízo G, Severiche C. Clasificación en subtipos intrínsecos de los carcinomas de mama analizados en un centro de patología de Medellín en el año 2011. CES Medicina. 2015; 29(1): 35-45.
Piper M, Warren A, Sbitany H. Oncoplastic breast surgery: current strategies. Gland surg. 2015; 4(2): 154-63.
Vázquez C. Cirugía del cáncer de mama: técnicas quirúrgicas de tratamiento y de reconstrucción, momento y tiempos de recuperación. Med. segur. trab. [Internet]. 2016; 62: 116-124. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2016000400013&lng=es.
Hernanz De La Fuente F, Gómez M. Mamoplastia oncoterapéutica. Una opción adecuada en la paciente con cáncer de mama y gigantomastia. Cir Esp. 2007; 82(1): 46-9.
Denewer A, Shahatto F, Elnahas W, Farouk O, Roshdy S, Khater A, et al. Therapeutic reduction mammoplasty in large-breasted women with cancer using superior and superomedial pedicles. Breast Cancer. Dove Med Press. 2012; 4: 167-72.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125): 1023-75.
Builes S, Acea B, García A, Cereijo C, Bouzón A, Mosquera O. Evaluation of the preoperative perception of quality of life and satisfaction of women with breast cancer using the BREAST-Q™ questionnaire. Cir Esp. 2020; 98(4): 212-8.
Pusic AL, Klassen A, Scott A, Klok J, Cordeiro PG, Cano SJ. Development of a New Patient Reported Outcome Measure for Breast Surgery: The BREAST-Q. Plast Reconstr Surg. 2009; 124(2): 345-53.
Perez V, Vela T, Mora A. Diagnóstico histopatológico y factores pronóstico en cáncer infiltrante de glándula mamaria. Rev Inst Nal Cancerol (Mex). 2008; 3(1): 7-17.
Gradishar W, Anderson B, Abraham J, Aft R, Agnese D, Allison K, et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Natl Compr Canc Netw. 2020; 18(4): 452-478.
Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45(2): 228-47.
World Health Organization. (1979). WHO handbook for reporting results of cancer treatment. World Health Organization. https://apps.who.int/iris/handle/10665/37200.
Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, del Vecchio M, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer. 1995; 31A(10): 1574-9.
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347(16): 1227-32.
Tanis E, van de Velde C, Bartelink H, van de Vijver M, Putter H, van der Hage J. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer. Eur J Cancer. 2012; 48(12): 1751-6.
Clough KB, Baruch J. La chirurgie plastique et le traitement conservateur du cancer du sein. Indication et résultats. Ann Chir Plast Esthet. 1992; (37): 682-769.
Hernanz F, Gómez M, Martínez F. Mamoplastia de reducción en la cirugía del cáncer de mama. Cir Esp. 2009; 85(3): 140-6.
Clough KB, Baruch J. Plastic surgery and conservative treatment of breast cancer. Indications and results. Ann Chir Plast Esthet. 1992; 37 (6): 682-92.
Shestah KC, Johnson RR, Greco RJ, Williams SL. Partial mastectomy and breast reduction as a valuable treatment option for patients with macromastia and carcinoma of the breast. Surg Gynecol Obstet. 1993; 177(1): 54-6.
Ettinger RE, Agarwal S, Izenberg PH, Beil RJ, Sherick DG. Bilateral Reduction Mammaplasty as an Oncoplastic Technique for the Management of Early-Stage Breast Cancer in Women with Macromastia. Eplasty. 2016; 16: e5.
Piper ML, Esserman LJ, Sbitany H, Peled AW. Outcomes Following Oncoplastic Reduction Mammoplasty: A Systematic Review. Ann Plast Surg [Internet]. 2016; 76(May): S222-S226. Disponible en: https://doi.org/10.1097/SAP.0000000000000720.
Navarro Martínez JJ, Navarro Campos BC, Navarro Campos LJ. Cirugía conservadora en cáncer de mama con técnica de reducción en mamas voluminosas. Rev Venez Oncol. 2016; 28(2): 78-86.
Clough KB, Cuminet J, Fitoussi A, Nos C, Mosseri V. Cosmetic sequelae after conservative treatment of breast cancer: classification and results of surgical correction. Ann Plast Surg. 1998; 41(5): 471-81.
Munhoz, AM, Montag E, Gemperli R. Oncoplastic breast surgery: indications, techniques and perspectives. Gland Surg. 2013; 2(3): 143-57.
Lonie S, Sachs R, Shen A, Hunter-Smith DJ, Rozen WM, Seifman M. A systematic review of patient reported outcome measures for women with macromastia who have undergone breast reduction surgery. Gland Surg. 2019; 8(4): 431-40.
Imahiyerobo TA, Pharmer LA, Swistel AJ, Talmor M. A comparative retrospective analysis of complications after oncoplastic breast reduction and breast reduction for benign macromastia: Are these procedures equally safe?. Ann Plast Surg. 2015; 75(4): 370-5.
Taboada Suárez A, Brea García B, González Álvarez E, Couto González I. Grado de satisfacción tras cirugía de hipertrofia mamaria severa. FILACP [Internet]. 2010; 36(1): 13-8. Disponible en: https://www.redalyc.org/articulo.oa?id=365537853003.
Jara Contreras R, Albornoz Garrido C, Valdés Rubilar M, Andrades Cvitanic P, Eazo Cortes , Danilla Enei S, et al. Traducción y Adaptación Transcultural al español (castellano) del Instrumento Breast-Q® Modulo Reconstrucción Mamaria. Rev Cir (Mex) [Internet]. 2020; 72(2). DOI: https://doi.org/10.35687/S2452-45492020002563.
Arias-Aliaga A, Vargas-Oliva J, Fernández-Gómez A. Resultados del tratamiento quirúrgico en pacientes con diagnóstico de cáncer de mama. MULTIMED [Internet]. 2020; 24. Disponible en: http://www.revmultimed.sld.cu/index.php/mtm/article/view/1852.
Programa Nacional De Consensos Inter-sociedades. Consenso nacional inter-sociedades: factores pronósticos y predictivos en cáncer de mama temprano.AM Argentina [Internet]. 2020; 2016: 1-23. Disponible en: https://www.samas.org.ar/archivos/consfacpron.pdf.
Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast cancer, version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Nati Compr Canc Netw [internet]. 18(4): 452-78. Disponible en: https://jnccn.org/view/journals/jnccn/18/4/article-p452.xml.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Médicas UIS